Feature | August 15, 2012| Dave Fornell

TAVR, EVAR Vascular Closure Device May Eliminate Need for Surgical Cut-Down

Transapical access closure

Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a transfemoral combined access and closure system to accomodate these larger sized percutaneous devices and arteriotomies. Introduced in sessions at the 2012 American College of Cardiology (ACC) and EuroPCR, the VasoStitch system is designed to reduce procedural complexity and eliminate the need for open surgical cut-downs and surgical closure of the vessel.

The company is also developing a similar transapical TAVR access and closure device to eliminate the need to sew surgical purse-string sutures at the apex of the heart prior to introducer placement. This may significanty shorten and simplify transapical valve replacement procedures.

The system uses a helical, corkscrew-shaped, barbed suturing needle that is advanced through the vessel wall and surrounding tissue prior to vessel access. Access is accomplished though the center of the suture needle coil. When the procedure is complete, a suture tail is pulled to close the vessel and activate a bioresorbable suture lock.

“At the present time, surgical means of arterial or cardiac access-and-closure for large-diameter, catheter-based interventions such as TAVI adds about 60 minutes to an already lengthy and elaborate procedure. As a result, a device that can duplicate the current ‘gold standard’ of surgical access and repair — but in a quicker and simpler, nonsurgical procedure — will surely stimulate the adoption of large-diameter cardiovascular and endovascular therapies, as well as improve the efficiency of patient management,” said David W. J. Smith, president and CEO of Danville, Calif.-based VasoStitch. “We are moving quickly toward our first-in-human milestone.”

For more information: www.vasostitch.com

Related Content

Cardioband, valtech, Edwards Lifesciences, transcatheter mitral repair, transcatheter tricuspid valve repair, transcatheter annuloplasty

An illustration of how the transcatheter Cardioband System can used as a non-surgical form on annuloplasty repair. 

News | Heart Valve Technology| December 02, 2016
December 2, 2016 — Edwards Lifesciences Corp.
Mitralign, Trialign System, tricuspid regurgitation, first transcatheter repair, cardiac implantable device lead, Piedmont
News | Heart Valve Technology| November 18, 2016
Mitralign Inc. announced the successful compassionate use treatment of a patient suffering from tricuspid regurgitation...
Sponsored Content | Videos | TCT| November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies
Sponsored Content | Videos | Heart Valve Technology| November 18, 2016
A discussion with Torsten Vahl, M.D., about advancements in transcatheter valve repair technology, including new devi
Sponsored Content | Videos | Heart Valve Technology| November 18, 2016
A discussion with Juan Granada, M.D., about transcatheter mitral valve advancements and device challenges at the Tran
Greenbaum, Henry Ford Hospital, LAMPOON procedure, mitral valve
News | Heart Valve Technology| November 10, 2016
November 10, 2016 — A Henry Ford Hospital cardiologist is pioneering a promising new procedure to improve the success
NeoChord, RECHORD Trial, first patient, DS1000 System, degenerative mitral regurgitation, DMR
News | Heart Valve Technology| November 10, 2016
NeoChord Inc. announced the first use of its DS1000 System in the United States as it enrolled the first patient in the...
Sponsored Content | Videos | Heart Valve Technology| November 09, 2016
A discussion with Michael Reardon, M.D.
transcaval valve replacement, Henry Ford Hospital, Detroit Michigan, success rate, JACC study, TCT 2016
News | Heart Valve Technology| November 09, 2016
November 9, 2016 — A pioneering way to access the heart for...
transcatheter aortic valve replacement, pacemakers, implantation, post-TAVR implantation, worse outcomes, study
News | EP Lab| November 09, 2016
Patients who undergo minimally invasive heart valve replacement, known as transcatheter aortic valve replacement (TAVR...
Overlay Init